Barclays PLC Cuts Holdings in Cardinal Health, Inc. $CAH

Barclays PLC reduced its position in Cardinal Health, Inc. (NYSE:CAH) by 23.7% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 1,208,599 shares of the company’s stock after selling 375,615 shares during the period. Barclays PLC’s holdings in Cardinal Health were worth $248,367,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of CAH. Norges Bank purchased a new position in shares of Cardinal Health in the 4th quarter worth $790,344,000. Wellington Management Group LLP boosted its stake in shares of Cardinal Health by 153.2% in the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after buying an additional 3,511,579 shares during the last quarter. Holocene Advisors LP boosted its stake in shares of Cardinal Health by 141.4% in the 3rd quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock worth $302,332,000 after buying an additional 1,128,358 shares during the last quarter. Marshall Wace LLP boosted its stake in shares of Cardinal Health by 1,328.1% in the 4th quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock worth $195,484,000 after buying an additional 884,648 shares during the last quarter. Finally, SG Americas Securities LLC boosted its stake in shares of Cardinal Health by 3,829.1% in the 4th quarter. SG Americas Securities LLC now owns 727,511 shares of the company’s stock worth $149,504,000 after buying an additional 708,995 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

Shares of Cardinal Health stock opened at $223.76 on Monday. Cardinal Health, Inc. has a one year low of $137.75 and a one year high of $233.60. The stock’s fifty day moving average is $203.21 and its 200 day moving average is $208.83. The stock has a market cap of $52.41 billion, a P/E ratio of 34.21, a P/E/G ratio of 1.22 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same period last year, the firm earned $2.35 EPS. Cardinal Health’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s payout ratio is 31.19%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on CAH. TD Cowen raised their price target on Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. Citigroup dropped their price target on Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Evercore decreased their target price on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. Robert W. Baird set a $248.00 target price on Cardinal Health in a report on Friday, May 1st. Finally, Wells Fargo & Company decreased their target price on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $246.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.